• Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Contact Us
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

Maze Therapeutics

Exclusive: Maze unveils their $191M pipeline, taking on Vertex and two long-sought conditions

March 24, 2021
insitro

Insitro raises $400M for machine learning-powered drug discovery efforts

March 15, 2021
Remix Therapeutics

Remix Therapeutics debuts with $81M to ‘reprogram’ disease-causing RNA

December 10, 2020
Everly Health

Demand for at-home testing propels Everlywell to $175M in new funding

December 10, 2020
Maze Therapeutics

Chutes & Ladders—Sanofi CSO Nabel steps down in favor of insider Nestle

October 9, 2020
GRAIL, Inc.

Illumina buying cancer-screening spinout Grail in blockbuster $8B biotech deal

September 21, 2020
Evonetix

Evonetix Extends DNA Synthesis Partnership With Semiconductor Firm Analog Devices

September 9, 2020
Lyell Immunopharma

Orca Bio, Lyell Immunopharma pen new pact to open up CAR-T for solid tumors

September 2, 2020
Cerevance

Biotech Startup Cerevance Extends Series B to $65 Million

July 21, 2020
Kinnate Biopharma

Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer

July 8, 2020
Page 8 of 25« First«...678910...20...»Last »

Please see important disclaimers in the Terms section.


©2022 Foresite Capital Management, LLC. Site by GOODLAB

    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
    Close
    • News
    • Blog
    • Foresite Labs
    • Contact Us
    • Home
    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
      • Blog
      • Careers
      • Contact Us
      • Disclosures
      • Home
      • Legal Disclaimers
      • Pardes Biosciences Legend
      • Privacy Policy
      • Strategy
      • Terms

    ©2025 Foresite Capital Management, LLC.

    Site by Goodlab

    Close